Beddingfield III Frederick 4
4 · Sienna Biopharmaceuticals, Inc. · Filed Jun 4, 2018
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Award
Stock Options (Right to buy)
2018-06-01+190,910→ 190,910 totalExercise: $15.08Exp: 2028-06-01→ Common Stock (190,910 underlying)
Holdings
- 112,614(indirect: See Footnote)
Common Stock
- 603,208
Common Stock
Footnotes (3)
- [F1]Includes 1,962 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 31, 2018.
- [F2]The shares are directly held by the Beddingfield Family Trust.
- [F3]Twenty-Five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from June 1, 2018, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.